Ozgur Yasar Akbal

Ozgur Yasar Akbal

Auto-generated profile, based on publicly available information

Ozgur Yasar Akbal

Univ Hlth Sci Turkey, Kosuyolu Heart Training & Res Hosp, Hamidiye Fac Med, Dept Cardiol, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ÖAÖzgür Yaşar Akbal
Özgür Yaşar Akbal
BKBerhan Keskin
Berhan Keskin
HTHacer Ceren Tokgöz
Hacer Ceren Tokgöz
AHAykun Hakgör
Aykun Hakgör
AKAli Karagoz
Ali Karagoz
CKCihangir Kaymaz
Cihangir Kaymaz
AngioJet rheolytic thrombectomy (ART) has been used as a catheter-based treatment for acute pulmonary embolism (PE). In this study, based on our 7-year experience with ART in patients with PE, we evaluated the efficacy and safety outcomes of ART. Our study is based on retrospective evaluation of 56 patients with high- and intermediate-high-risk PE, with an average age of 62 years [interquartile range (IQR) 50–73 years] who underwent ART. High and intermediate-high risks were noted in 21.4% and 78.6% of the patients, respectively. The ART duration was 304 (IQR: 246–468) seconds. Measures of obstruction, right to left ventricle diameter ratio, right to left atrial diameter ratio, and pulmonary arterial pressures were improved (p<0.001 for all). During the hospital stay, acute renal failure, major and minor bleeding, and mortality rates were 37.5%, 7.1%, 12.5%, and 8.9%, respectively. Aging related to post-procedural nephropathy while high-risk status was associated with in-hospital mortality (p=0.006) and long-term mortality. ART resulted in significant and clinically relevant improvements in the pulmonary arterial thrombotic burden, right ventricle strain, and hemodynamics in patients with PE at high and intermediate-high risk. Aging increased the risk of post-procedural nephropathy, whereas baseline high-risk status predicted in-hospital and long-term mortality.

28 November 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
HTHacer Ceren Tokgoz
Hacer Ceren Tokgoz
OAOzgur Yasar Akbal
Ozgur Yasar Akbal
AKAli Karagoz
Ali Karagoz
BKBarkın Kültürsay
Barkın Kültürsay
SÜSeda TANYERİ ÜZEL
Seda TANYERİ ÜZEL
CKCihangir Kaymaz
Cihangir Kaymaz
Pulmonary arterial hypertension,mortality,pregnancy

1 September 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
SKSeyhmus Kulahcioglu
Seyhmus Kulahcioglu
HTHacer Ceren Tokgoz
Hacer Ceren Tokgoz
OAOzgur Yasar Akbal
Ozgur Yasar Akbal
BKBerhan Keskin
Berhan Keskin
BKBarkın Kültürsay
Barkın Kültürsay
CKCihangir Kaymaz
Cihangir Kaymaz
Acute pulmonary embolism,ultrasound-assisted thrombolysis,eosinophil to monocyte ratio,rheolytic thrombectomy,prognostic biomarkers

1 October 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
CKCihangir Kaymaz
Cihangir Kaymaz
SÜSeda TANYERİ ÜZEL
Seda TANYERİ ÜZEL
HTHacer Ceren Tokgoz
Hacer Ceren Tokgoz
OAOzgur Yasar Akbal
Ozgur Yasar Akbal
AKAli Karagoz
Ali Karagoz
NONihal Ozdemir
Nihal Ozdemir
Macitentan,pulmonary arterial hypertension,Eisenmenger syndrome,REVEAL-Lite 2,COMPERA,SPAHR

1 January 2024 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
CKCihangir Kaymaz
Cihangir Kaymaz
BKBarkın Kültürsay
Barkın Kültürsay
HTHacer Ceren Tokgöz
Hacer Ceren Tokgöz
AHAykun Hakgor
Aykun Hakgor
BKBerhan Keskin
Berhan Keskin
NÖNihal Özdemir
Nihal Özdemir
Background: AngioJet rheolytic thrombectomy (ART) system has been widely used as a catheter-directed treatment (CDT) method in acute pulmonary embolism (PE), however, there has been a controversy regarding the safety of its use. In this systematic review and meta-analysis, we evaluated the efficacy and safety outcomes of ART in patients with PE. Methods: Our meta-analysis have been based on search in the MEDLINE, EMBASE, and Cochrane Library for studies published up to August 2022. The primary outcomes were overall pooled rates of major bleeding (MB) and minor bleeding (mB), worsening renal function (WRF), bradycardia/conduction disturbance (BCD), and PE-related and all- cause mortality in patients who underwent ART. Results: Among the 233 studies documented at initial search, 24 studies were eligible for meta-analysis, and a total of 427 PE patients who underwent ART were evaluated. Overall pooled rates of MB and mB were 9.6% (95% CI 5.9%-15.2%) and 9.2% (95% CI 6.1%13.6%), transient BCD and WRF were 18.2% (95% CI 12.4%-26%) and 15% (95% CI 10%21.8%), and PE-related death and all-cause death were 12.7% (95% CI 9.1%-17.3%) and 15% (95% CI 11%-20%), respectively. However, significant heterogeneity and some evidence of funnel plot asymmetry and publication bias were noted for MB, BCD and WRF, but not for PE-related death and all-cause death. Conclusion: Overall pooled rates of bleeding events, BCD and WRF episodes, PE-related death and all-cause death may be considered as encouraging results for efficacy and safety issues of ART utilization in specific scenarios of acute PE, and a reappraisal for black-box warning on ART seems to be necessary.

3 June 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ZBZubeyde Bayram
Zubeyde Bayram
ITIstanbul- Turkey
Istanbul- Turkey
CDCem Dogan
Cem Dogan
RAREZZAN DENİZ ACAR
REZZAN DENİZ ACAR
SESuleyman Efe
Suleyman Efe
NONihal Ozdemir
Nihal Ozdemir
Objective: Increased pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) are important prognostic factors in patients with heart transplantation (HT). It is well known that severe mitrel regurgitation increases pulmonary pressures. However, the European Society of Cardiology and the 6th World Symposium of pulmonary hypertension (PH) task force redefined severe functional mitral regurgitation (FMR) and PH, respectively. We aimed to investigate the effect of severe FMR on PAP and PVR based on these major redefinitions in patients with HT. Methods: A total of 212 patients with HT were divided into 2 groups: those with severe FMR (n=70) and without severe FMR (n=142). Severe FMR was defined as effective orifice regurgitation area >= 20 mm(2) and regurgitation volume >= 30 mL where the mitrel valve was morphologically normal. A mean PAP of >20 mm Hg was accepted as PH. Patients with left ventricular ejection fraction <= 25% were included in the study. Results: The systolic PAP, mean PAP, and PVR were higher in patients with severe FMR than in those without severe FMR [58.5 (48.0-70.2) versus 45.0 (36.0-64.0), p= 3 and 5 WU [odds ratio (OR): 2.0, 95% confidence interval (CI): 1.1-3.6, p=0.009; and OR: 3.2, 95% CI: 1.5-6.7, p=0.002]. The multivariate regression analysis results revealed that presence of severe FMR is an independent risk factor for PVR >= 3 WU and presence of combined pre-post-capillary PH (OR: 2.23, 95% CI: 1.30-3.82, p=0.003 and OR: 2.30, 95% CI: 1.25-4.26, p=0.008). Conclusion: Even in the updated definition of FMR with a lower threshold, severe FMR is associated with higher PVR, systolic PAP, and mean PAP and appears to have an unfavorable effect on pulmonary hemodynamics in patients with HT.